Busky Joseph M.

CFO Busky Joseph M. bought 3,370 shares of QDEL at $23.66 on 2026-02-13, bringing holdings to 10,290 shares. Stock down -45.0% from 52-week high.

CFO Joseph M. Busky purchased 3,370 shares at $23.66, representing a 48.7% increase in his holdings to 10,290 shares. This transaction occurs as QuidelOrtho trades 45.0% below its 52-week high and has declined 31.3% over the past 30 days, following an annual revenue decline of 7.2% and negative net income of $-733.0M in the latest quarter. Notably, two other insiders also bought within the past 14 days, forming a cluster pattern. However, Busky's cross-ticker track record shows a 0.00% 90-day win rate across 2 prior buys with an average 90-day return of -9.7%, and his same-ticker history at QDEL demonstrates only 1 of 1 prior buys reaching a positive 90-day return, suggesting limited predictive value for this purchase. The timing and deteriorating fundamentals warrant observation but do not yet constitute a strong confidence signal.

CFO Busky Joseph M. buys 4,770 shares of QDEL at $26.06 (Nov 24), raising stake 221.9%; stock -40.9% from 52-week high amid -7.2% annual revenue decline and -$733.0M net loss.

Joseph M. Busky, Chief Financial Officer of QuidelOrtho Corp, purchased 4,770 shares at $26.06 on 2025-11-24, increasing his holdings from 2,150 to 6,920 shares—a 221.9% increase in position size. This comes as QDEL trades at $28.14, down 40.9% from its 52-week high of $47.61, while the company grapples with fundamental headwinds: revenue declined 7.2% year-over-year to $699.9M, and the company posted a net loss of -$733.0M over its most recent full fiscal year. Additionally, 2 other insiders purchased shares within the past 14 days, indicating a broader cluster buy pattern among company leadership. His cross-ticker track record shows 0 out of 1 prior buy decisions were well-timed at the 90-day mark, with an average 90-day return of -9.7% across his open-market history, suggesting prior purchases have not been followed by stock appreciation.